Studiencode: PRO 2013
| Institution: | Pierrel Research Europe GmbH | Auftraggeber: | LETI Pharma GmbH |
| Titel der NIS: | Non-interventional Study in Allergic Patients Suffering from Grass Pollen Induced Rhinitis/Rhinoconjunctivitis with or without Asthma. Retrospective Assessment of the Efficacy of a Perennial Specific Immunotherapy on the Allergy Symptoms / Disease Activity during the Pollen Season | ||
| Ziel der NIS: | Patient reported outcome on the disease activity, intensity of allergic symptoms, intake of rescue medication and global assessment during the pollen season 2013 after 5-6 months of treatment with 4 different doses of Depigoid Phleum: 100, 1000, 5000 or 10000 DPP/ml |
||
| Ort der Durchführung: | multinational | NIS angefordert: | nein |
| Patientenanzahl insgesamt: | 275 | Anzahl Ärzte insgesamt: | 40 |
| Patientenanzahl in Deutschland: | 151 | Ärzte in Deutschland: | 25 |
| Anzeige am: | 20.11.2013 | Geplanter Beginn: | 09.12.2013 | Geplantes Ende: | 02.03.2014 |
| Angezeigtes Ende der NIS am: 04.08.2014 | |||||
| Arzneimittelbezeichnung | INN | Zulassungs-Nr. | ATC-Code | Substanzklasse |
|---|---|---|---|---|
| Depigoid Phleum | depigmented and glutaraldehyde polymerised grass allergen extract adsorbed to aluminium hydroxide | Not applicable | V01AA02 | allergen extracts |
| Depigoid Phleum | depigmented and glutaraldehyde polymerised grass allergen extract adsorbed to aluminium hydroxide | Not applicable | V01AA03 | allergen extracts |
| Depigoid Phleum | depigmented and glutaraldehyde polymerised grass allergen extract adsorbed to aluminium hydroxide | Not applicable | V01AA05 | allergen extracts |
| Depigoid Phleum | depigmented and glutaraldehyde polymerised grass allergen extract adsorbed to aluminium hydroxide | Not applicable | V01AA20 | allergen extracts |
